Post by
retiredcf on Jan 12, 2025 11:59am
The Road Ahead
DRX is a cyclical business. As a result, its earnings and share price can be highly volatile over the years. DRX is trading at a very cheap multiple of 4.8x Forward P/E, and management has been repurchasing shares aggressively in recent quarters. We think investors need some patience with the name. We think DRX could potentially see a significant recovery in the next cycle if earnings reaccelerate over the next few years. (5iResearch)